Keywords: گینا; Asthma; Drug therapy; Montelukast; Pediatrics; Randomized controlled trial; GINA; Global Initiative for Asthma; EPR-3; Expert Panel Reports 3; JGCA; Japanese guideline for childhood asthma; ICS; inhaled corticosteroid; SpO2; oxygen saturation of periphera
مقالات ISI گینا (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: گینا; Adult asthma; Airway hyperresponsiveness; Asthma management; ICS; Step-down; Innate immunity; Regulatory T cell; IL-10; IL-33; ACh; Acetylcholine dichloride; Feno; Fractional exhaled nitric oxide; GINA; Global Initiative for Asthma; Hist; Histamine dihydr
Keywords: گینا; Adverse drug events; Effectiveness; Exacerbations; Omalizumab; Severe asthma; ADRs; adverse drug reaction; AEs; adverse events; GETE; global evaluation of treatment effectiveness; GINA; Global Initiative for Asthma; HCRU; health care resource utilization;
Keywords: گینا; Allergic asthma; Cluster analysis; Phenotypes; Inheritance; BMI; Body mass index; FENO; Fractional exhaled nitric oxide; GEMA; Spanish Guideline on the Management of Asthma; GINA; Global Initiative for Asthma; LABA; Long-acting β-agonists; SARP; Severe A
Keywords: گینا; a.u; Arbitrary units; AUC; area under the curve; BA; bronchial asthma; CL; chemiluminescence; CI; confidence interval; CR3, CR4; complement receptors 3 and 4; EC50; half maximal effective concentration; FEV1; forced expiratory volume in 1Â s; FVC; forced
Keywords: گینا; AMA; American Medical Association; ACMG; American College of Medical Genetics and Genomics; CF; cystic fibrosis; CLIA; Clinical Laboratory Improvement Amendments; DTC; direct-to-consumer; FDA; Food and Drug Administration; GINA; Genetic Information Non-Di
Keywords: گینا; Asthma; Elderly people; Asthma phenotypes; Asthma medications; Drug claims data; ACO; Asthma-COPD overlap; AQLQ; Asthma Quality of Life Questionnaire; ATC; Anatomical Therapeutic Chemical; BMI; Body mass index; CI; Confidence interval; COPD; Chronic obstr
Keywords: گینا; Severe asthma; Status asthmaticus; Healthcare resource utilization; Observational study; Cohort; ACT; Asthma Control Test; ACQ-5; Asthma Control Questionnaire-5 items; COBRA; “Cohorte Obstruction Bronchique et Asthme” cohort; GINA; Global Initiative f
Keywords: گینا; ACQ; asthma control questionnaire; AHR; airway hyperresponsiveness; Anti-IL5; anti-interleukin 5; AQLQ; asthma quality of life questionnaire; ASM; airway smooth muscle; BAL; bronchoalveolar lavage; BT; Bronchial Thermoplasty; ECM; extracellular matrix; ED
Keywords: گینا; Chinese herbal medicine formula; Acute asthma; Randomized controlled trial; Inflammatory cytokines; Proof-of-concept; ASHMI; antiasthma simplified herbal medicine intervention; CRP; C-reactive protein; ELISA; enzyme - linked immunosorbent assay; ERS; Euro
Keywords: گینا; Asthma exacerbation; asthma guidelines; Composite Asthma Severity Index; Seasonal Asthma Exacerbation Prediction Index; trajectories of lung growth; CASI; Composite Asthma Severity Index; COPD; Chronic obstructive pulmonary disease; EPR-3; Expert Panel Re
Keywords: گینا; ACT; asthma control test; AQLQ; asthma quality of life questionnaire; COPD; chronic obstructive pulmonary disease; FEV1; forced expiratory volume in the first second; GINA; global initiative for asthma; HRQoL; health related quality of life; ICS; inhaled
Keywords: گینا; SMART; ICS/LABA; Symbicort Maintenance And Reliever Therapy; GINA; Asthma Control Test; ACT; Asthma Control Test; COPD; chronic obstructive pulmonary disease; GINA; Global Initiative for Asthma; ICS; inhaled corticosteroid; LABA; long-acting inhaled β2-a
Keywords: گینا; Asthma-chronic obstructive pulmonary disease overlap syndrome; Sinonasal inflammation; Lund-Mackay staging score; ACOS; Asthma-chronic obstructive pulmonary disease overlap syndrome; COPD; Chronic obstructive pulmonary disease; CT; Computed tomography; FE
Keywords: گینا; Asthma; Mepolizumab; Placebo; Safety; Treatment efficacy; ACQ; Asthma Control Questionnaire; AE; adverse event; CI; confidence interval; ED; emergency department; FEV1; forced expiratory volume in 1Â second; FVC; forced vital capacity; GINA; Global Initia
Keywords: گینا; Asthma; Control; Biologics; Eosinophilic asthma; Severe asthma; Uncontrolled asthma; DDP-4; dipeptidyl peptidase 4; Feno; fraction of exhaled nitric oxide; GINA; Global Initiative for Asthma; ICS; inhaled corticosteroid; LABA; long-acting beta2 agonist; S
Keywords: گینا; Eosinophils; biomarkers; severe eosinophilic asthma; DREAM; Dose Ranging Efficacy and safety With Mepolizumab in Severe Asthma; Feno; Fraction of exhaled nitric oxide; GINA; Global Initiative for Asthma; ICS; Inhaled corticosteroid; MENSA; Mepolizumab Adj
Keywords: گینا; ACOS; asthma-COPD overlap syndrome; BD; bronchodilation; CARAT; control of allergic rhinitis and asthma test; COPD; chronic obstructive pulmonary disease; FENO; fractional exhaled nitric oxide; FEV1; forced expiratory volume in 1Â s; FVC; forced vital cap
Keywords: گینا; Asthma; Systematic assessment; Difficult; Severe; Comorbidity; ACT; Asthma Control Test; AQLQ; Asthma Quality of Life Questionnaire; CRS; chronic rhinosinusitis; DB; dysfunctional breathing; GINA; Global Initiative for Asthma;
Keywords: گینا; Asthma; Asthma control; Symptom control; Variability; Heterogeneity; Observational studies; CI; Confidence interval; FEV1; Forced expiratory volume in 1 second; FVC; Forced vital capacity; GINA; Global initiative for asthma; MPR; Medication possession rat
Keywords: گینا; Obesity; asthma; phenotype; nuclear magnetic resonance; metabolomics; profiling; exhaled breath condensate; biomarkers; BMI; Body mass index; 1D; One-dimensional; 2D; 2-dimensional; EBC; Exhaled breath condensate; FVC; Forced vital capacity; GINA; Global
Keywords: گینا; Administrative data; Corticosteroid; Comorbidities; Allergist; Asthma specialist; Asthma control; Blood eosinophil count; Chronic oral corticosteroid use; Controller medication; Exacerbations; Asthma guidelines; Managed care; Persistent asthma; Short-acti
Keywords: گینا; Adult asthma; Severe asthma; Exacerbation; Smokers; Predictors; ACQ; asthma control questionnaire; AQLQ; asthma quality of life questionnaire; BMI; body mass index; FeNO; fraction of exhaled nitric oxide; FEV1; forced expiratory volume in 1Â s; FVC; force
Keywords: گینا; airway inflammation; asthma; cough; ACQ; Asthma Control Questionnaire; BHR; bronchial hyperresponsiveness; eNO; exhaled nitric oxide; GINA; Global Initiative for Asthma;
Keywords: گینا; Asthma; small airways; acinus; physiology; ACQ; Asthma Control Questionnaire; ADC; Apparent diffusion coefficient; CDI; Convection-dependent inhomogeneity; CT; Computed tomography; DCDI; Diffusion-convection-dependent inhomogeneity; FRC; Functional resi
Keywords: گینا; Asthma; asthma severity; fibrocytes; peripheral blood; biomarker; APC; Allophycocyanin; ATS; American Thoracic Society; Col1; Collagen 1; EGFR; Epithelial growth factor receptor; FACS; Fluorescence-activated cell sorting; FVC; Forced vital capacity; GINA;
Keywords: گینا; Asthma; chronic obstructive pulmonary disease; asthma-chronic obstructive pulmonary disease overlap syndrome; definition; prevalence; ACOS; Asthma-COPD phenotype or overlap syndrome; COPD; Chronic obstructive pulmonary disease; GINA; Global Initiative f
Keywords: گینا; Asthma; Phenotype; Persistent airflow obstruction; Airways inflammation; Cluster analysis; ANOVA; analysis of variance; ATS; American Thoracic Society; BHR; bronchial hyperresponsiveness; BMI; body mass index; COPD; chronic obstructive pulmonary disease;
Keywords: گینا; Airway inflammation; Airway remodeling; Airway reversibility; Bronchodilator; Lung function; ACT; Asthma Control Test; BDR; Bronchodilator reversibility; FeNO; Exhaled nitric oxide fraction; FEV1; Forced expiratory volume in 1 second; FVC; Forced vital ca
Keywords: گینا; Pediatric acute asthma exacerbations; Clinical prediction rule; Hospitalization; APR; Asthma prediction rule; BMI; Body mass index; CCS; Corticosteroid; CPR; Clinical prediction rule; df; Degrees of freedom; eNO; Exhaled nitric oxide; %FEV1; %-predicted f
Keywords: گینا; ACQ; Asthma Control Questionnaire; CART; classification and regression tree; Feno; fraction of exhaled nitric oxide; GINA; Global Initiative for Asthma; HR; high reversibility; IPI; Immune Profile Index; LR; low reversibility; NWC; not well controlled; PP
Keywords: گینا; Asthma; Lung function; Macrolide; Meta-analysis; CNKI; China national knowledge internet; WMD; weighed mean difference; SMD; standardized mean difference; PEF; peak expiratory flow; AHR; airway hyper-responsiveness; FEV1/FVC; the ratio of forced expirator
Keywords: گینا; Asthma; T lymphocytes; cytokines; mast cells; phenotype; endotype; regulatory T; TH17; TH2; mucosal-associated invariant T-cell; ACQ; Asthma Control Questionnaire; BAL; Bronchoalveolar lavage; BNA; Bayesian network analysis; eNO; Exhaled nitric oxide; FOX
Keywords: گینا; Asthma; asthma control; budesonide/formoterol maintenance and reliever therapy; exacerbations; Global Initiative for Asthma; predictors; risk score; ACQ-5; 5-Item Asthma Control Questionnaire; ADAS; Asthma Disease Activity Score; BMI; Body mass index; BUD
Keywords: گینا; Asthma; Control; Guidelines; Management; Symptoms; Survey; Treatment; AIM; Asthma Insight and Management; AIR; Asthma Insight and Reality; AP; Asia-Pacific; EPR-3; National Asthma Education and Prevention Program Expert Panel Report 3; EUCAN; Europe and C
Keywords: گینا; Adult-onset asthma; new-onset asthma; asthma severity; prospective follow-up study; predictors; smoking; ACQ; Asthma Control Questionnaire; AMC; Academic Medical Centre; COPD; Chronic obstructive pulmonary disease; FVC; Forced vital capacity; GINA; Global
Keywords: گینا; β2-AR; β2-adrenoreceptor; ASM; airway smooth muscle; BI; Bliss independence; COPD; chronic obstructive pulmonary disease; CRC; concentration-response curve; E; effect; EFS; electrical field stimulation; ECn; effective concentration for n% of maximal eff
Keywords: گینا; Childhood severe asthma; Childhood difficult-to-treat asthma; Severe asthma phenotypes; Childhood severe asthma treatment; Review; ACQ; Asthma Control Questionnaire; ACT; Asthma Control Test; ATS; American Thoracic Society; BMI; Body mass index; CT; Compu
Keywords: گینا; Allergic asthma; Anti-IgE; Exacerbations; Omalizumab; ATE; Arterial thromboembolic event; ED; Emergency department; EXCELS; The Epidemiologic Study of Xolair (omalizumab); FDA; US Food and Drug Administration; FeNO; Fraction of exhaled nitric oxide; GETE;
Keywords: گینا; Ion channel; sensory; asthma; irritant; chemical; exacerbation; cough; CT; Cycle threshold; ER; Endoplasmic reticulum; GAPDH; Glyceraldehyde-3-phosphate dehydrogenase; GINA; Global Initiative for Asthma; IHC; Immunohistochemistry; IQR; Interquartile range
Keywords: گینا; Airway inflammation; Airway obstruction; Airway remodeling; Asthma exacerbation; Inhaled corticosteroids; Lung function; ACT; Asthma Control Test; CRS; chronic rhinosinusitis; FeNO; exhaled nitric oxide fraction; GERD; gastro-esophageal reflux disease; GI
Keywords: گینا; acute asthma; Emergency Department; GINA; hospitalization; modified pulmonary index score;
Definition and diagnosis of asthma-COPD overlap (ACO)
Keywords: گینا; Airway responsiveness; Allergic rhinitis; CT; Eosinophil; Exhaled NO; ACO; Asthma-COPD overlap; COPD; Chronic Obstructive Pulmonary disease; FeNO; Fractional exhaled nitric oxide; GINA; Global Initiative for Asthma; GOLD; Global Initiative for Chronic O
Epidemiology of asthma-chronic obstructive pulmonary disease overlap (ACO)
Keywords: گینا; Asthma-chronic obstructive pulmonary disease (ACO); Asthma; COPD; Exacerbations; Prevalence of ACO; COPD; chronic obstructive pulmonary disease; ACO; asthma-COPD overlap; GINA; Global Initiative for Asthma; GOLD; Global Initiative for Chronic Obstructive
Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma
Keywords: گینا; Tiotropium; Long-acting muscarinic antagonist; Long-acting β2-agonist; Inhaled corticosteroids; Asthma; ACRN; Asthma Clinical Research Network; AE; adverse event; B16-Arg/Arg; arginine single nucleotide polymorphism at amino acid 16 in the β2-adrenergic
Identifying Patient Attitudinal Clusters Associated with Asthma Control: The European REALISE Survey
Keywords: گینا; Asthma; Attitudes; Beliefs; Cluster; Control; Management; Patient; BIC; Bayesian information criterion; GINA; Global Initiative for Asthma; HCP; Health care professional; LCA; Latent class analysis; REALISE; REcognise Asthma and LInk to Symptoms and Exper
The Tempest: Difficult to Control Asthma in Adolescence
Keywords: گینا; Severe asthma; Adolescent; Phenotype; Biologics; Difficult-to-treat asthma; Adherence; Psychosocial; ACT; Asthma Control Test; ATS; American Thoracic Society; BT; bronchial thermoplasty; ERS; European Respiratory Society; FDA; Food and Drug Administration
The Journal of Allergy and Clinical Immunology: In Practice 2017 Year in Review
Keywords: گینا; Angioedema; Allergy; Asthma; Anaphylaxis; Atopic dermatitis; Contact dermatitis; Drug allergy; Eosinophilic esophagitis; Eosinophilia; Food allergy; Immunodeficiency; Immunotherapy; Rhinitis; Rhinosinusitis; Urticaria; AAAAI; American Academy of Allergy A
Asthma control in adults in the Middle East and North Africa: Results from the ESMAA study
Keywords: گینا; Asthma control; GINA; ACT; Middle East; North Africa; ESMAA;
Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells
Keywords: گینا; Type 3 innate lymphoid cells; immature transitional regulatory B cells; regulatory B cells; tonsils; allergy; asthma; IL-10; immunoregulation; immune tolerance; APC; Allophycocyanin; APRIL; A proliferation-inducing ligand; BAFF; B cell-activating factor